Next, we compared the 1250 microglial DEGs identified between treatment with rh Bri2 BRICHOS R221E or veh in AppNL-G-F mice (Fig. 6B, D) with those identified in previously published studies of genes and microglial populations found to be relevant in AD and AD model mice (Fig. 8). This evidence concerns the gene ITM2B and Alzheimer disease.